J. John

发表

Kinetics of interaction of nucleotides with nucleotide-free H-ras p21.

R. Goody, J. John, R. Sohmen, 1990, Biochemistry.

Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation

W. Kabsch, E. Pai, K. Holmes, 1989, Nature.

Kinetic and structural analysis of the Mg(2+)-binding site of the guanine nucleotide-binding protein p21H-ras.

I. Schlichting, R. Goody, I. Vetter, 1993, The Journal of biological chemistry.

Biochemical and crystallographic characterization of a complex of c-Ha-ras p21 and caged GTP with flash photolysis.

I. Schlichting, E. Pai, R. Goody, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Mutational andKinetic Analyses oftheGTPase-Activating Protein (GAP)-p2l Interaction: TheC-Terminal DomainofGAP IsNot Sufficient forFullActivity

J. John, H. Roché, R. Clark, 1992 .

Development, Characterization and In-Vitro Evaluation of Azithromycin Niosomes

J. John, 2018 .

High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both α and γ interferons

I. Kerr, J. John, G. Stark, 1991 .

Biochemical Characterization ofEquineHerpesvirus Type3- Induced Deoxythymidine Kinase Purified fromLytically Infected HorseEmbryoDermalFibroblasts

J. John, M. Barnett, 1980 .

Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules

W. Kabsch, I. Schlichting, E. Pai, 1990, Cell.

Characterisation of the metal-ion-GDP complex at the active sites of transforming and nontransforming p21 proteins by observation of the 17O-Mn superhyperfine coupling and by kinetic methods.

H. Kalbitzer, R. Goody, J. John, 1987, European journal of biochemistry.

Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

G. Stark, I. Kerr, J. John, 1989, Molecular and cellular biology.

The Three-Dimensional Structure of P21 in the Catalytically Active Conformation and Analysis of Oncogenic Mutants

W. Kabsch, I. Schlichting, E. Pai, 1991 .

Crystallization and preliminary X-ray analysis of the human c-H-ras-oncogene product p21 complexed with GTP analogues.

E. Pai, R. Goody, J. John, 1989, Journal of molecular biology.

Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant.

W. Kabsch, E. Pai, J. John, 1991, Environmental health perspectives.

High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

G. Stark, I. Kerr, J. John, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons

G. Stark, I. Kerr, J. John, 1991, Molecular and cellular biology.

ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons

J. John, A. Wittinghofer, R. Heumann, 1989, Neuron.

Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats

J. John, S. Gatermann, R. Marre, 1989, Infection and immunity.

The Adenylate Cyclase System and Prostaglandin Production in Human Parietalis Decidua

J. John, N. Hassan, 1992 .

Substrate and product structural requirements for binding of nucleotides to H-ras p21: the mechanism of discrimination between guanosine and adenosine nucleotides.

I. Schlichting, R. Goody, J. John, 1995, Biochemistry.

ENYEART Voltage-gated K + Currents in Bovine Fasciculata Cells

J. John, 2003 .

Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide‐binding site.

R. Goody, J. John, J. Feuerstein, 1986, The EMBO journal.